Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
209.00    1.50 (0.72%)
Bid:
208.50
Ask:
209.00
Spread: 0.50 (0.24%)
Market Cap: £556.33m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

£20m Share Buyback Programme

10 Mar 2026 07:01

RNS Number : 9454V
Costain Group PLC
10 March 2026
 

 

10 March 2026

On-market Share Buyback Programme of £20m

 

Costain Group PLC ("Costain" or the "Group") today announces the launch of an on-market share buyback programme (the "Buyback") for a maximum aggregate consideration of £20m.

This follows the intention set out in the announcement dated 26 January 2026, which provided an update on the Group's new pension scheme agreement, enhanced shareholder returns and FY 25 trading. The removal of the dividend parity arrangement, as announced in the update, removed a significant constraint that was on Costain in respect of returns to shareholders.

Having considered the new agreement, the Group's cash performance and ongoing capital requirements, the Board has concluded that an on-market share buyback programme for a maximum aggregate consideration of £20m (excluding stamp duty and expenses) is an appropriate and value-enhancing use of cash, while maintaining the Group's financial flexibility to continue to invest in its strategy to deliver sustainable growth and attractive returns.

Any ordinary shares purchased by the Company will be cancelled and, accordingly, the Buyback will reduce the Company's share capital.

Details of the Buyback

Costain has instructed Panmure Liberum Limited ("Panmure Liberum") and Investec Bank plc ("Investec") to execute the Buyback. Costain has entered into a non-discretionary and irrevocable instruction with Panmure Liberum and Investec, pursuant to which Panmure Liberum (in respect of the First Tranche) and Investec (in respect of the Second Tranche) will each purchase the Company's ordinary shares of 1 pence each ("Ordinary Shares") for up to a maximum consideration of £10m for each tranche, each acting severally as riskless principal. The First Tranche will commence immediately. The Second Tranche will commence following completion of the First Tranche and it is anticipated it will end no later than 31 December 2026, subject to market conditions.

The maximum number of Ordinary Shares that can be purchased in aggregate under the First Tranche and Second Tranche is 20,481,508, being the number of shares the Company is authorised to purchase pursuant to the authority granted by shareholders at the Company's 2025 annual general meeting (the "2025 AGM") and any subsequent authority.

Panmure Liberum and Investec will make their trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company, within the terms and pre-set parameters of the Buyback.

Any purchase of Ordinary Shares under the Buyback will take place in open market transactions and may be made from time to time depending on market conditions, share price and trading volumes. The Buyback will be effected under the general authority to repurchase Ordinary Shares granted by the Company's shareholders at the 2025 AGM and in accordance with Chapter 12 of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No 596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they form part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018), including where relevant pursuant to the UK Market Abuse Regulation.

Any purchase of Ordinary Shares pursuant to the Buyback will be announced by no later the end of the 7th daily market session following the calendar day on which such transaction occurred.

The Company will make further announcements in due course following the completion of any repurchases. There is no guarantee that the Buyback will be implemented in full or that any Ordinary Shares will be repurchased by the Company. The Buyback will not impact the Company's existing Ordinary Share dividend policy, which will continue unaffected through the regular awards of interim and final dividends. At the time of this announcement, the Company's share capital comprises 266,714,895 Ordinary Shares with voting rights.

Enquiries:

 

Investors and analysts matt.jones@costain.com

Matt Jones, Costain +44 (0) 7860 922341

 

Financial media - Headland costain@headlandconsultancy.com

Andy Rivett-Carnac +44 (0) 7968 997 365

Charlie Twigg +44 (0) 7946 494 568

 

Notes to editors

 

Costain improves people's lives by creating connected, sustainable infrastructure that enables people and the planet to thrive. Through the delivery of predictable, best-in-class solutions across the transport, water, energy and defence markets, we are creating a sustainable future and securing a more prosperous, resilient and decarbonised UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKLFBQXLLBBZ
Date   Source Headline
11th Jan 201812:32 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSYear End Trading Update
2nd Jan 20188:00 amRNSTotal Voting Rights
2nd Jan 20188:00 amRNSBlock listing Interim Review
18th Dec 201711:50 amRNSHolding(s) in Company
14th Dec 20177:00 amRNSManagement Consultancy Framework Appointment
8th Dec 20178:00 amRNSDirector/PDMR Shareholding
30th Nov 20178:00 amRNSTotal Voting Rights
28th Nov 20173:18 pmRNSHolding(s) in Company
24th Nov 201711:28 amRNSBoard Notification - External Directorship
23rd Nov 20172:48 pmRNSHolding(s) in Company
17th Nov 201710:13 amRNSAppointment of Non Executive Director
1st Nov 201711:21 amRNSDirector/PDMR Shareholding
1st Nov 201711:16 amRNSTotal Voting Rights
26th Oct 20177:00 amRNSBlock Listing Application
25th Oct 20172:22 pmRNSDirector/PDMR Shareholding
20th Oct 20173:42 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSDividend - Scrip Alternative
29th Sep 20177:00 amRNSGreater Manchester Waste contract
25th Sep 20172:21 pmRNSDirector/PDMR Shareholding
21st Sep 201710:10 amRNSScrip Dividend Reference Price
15th Sep 20179:39 amRNSHolding(s) in Company
4th Sep 201710:37 amRNSHolding(s) in Company
24th Aug 20177:00 amRNSGreater Manchester Waste contract
23rd Aug 20177:00 amRNSHalf-year Report
1st Aug 20177:00 amRNSContract
20th Jul 20178:45 amRNSHolding(s) in Company
17th Jul 20178:12 amRNSHigh Speed Two "minded to award" Costain contracts
13th Jul 201712:19 pmRNSRe: Directorate
4th Jul 20177:00 amRNSTrading Update
30th Jun 20179:00 amRNSBlock listing Interim Review
31st May 201712:00 pmRNSTotal Voting Rights
16th May 20177:00 amRNSDividend - Scrip Alternative
8th May 20174:55 pmRNSResult of AGM
8th May 20177:00 amRNSAGM Statement
2nd May 20174:37 pmRNSGreater Manchester Waste contract
28th Apr 20171:56 pmRNSTotal Voting Rights
26th Apr 20175:06 pmRNSHolding(s) in Company
13th Apr 201710:52 amRNSScrip Dividend Reference Price
6th Apr 20179:40 amRNSDirector/PDMR Shareholding
5th Apr 201710:02 amRNSHolding(s) in Company
4th Apr 20174:16 pmRNSHolding(s) in Company
3rd Apr 20173:41 pmRNSHolding(s) in Company
31st Mar 201710:07 amRNSTotal Voting Rights
24th Mar 20179:28 amRNSHolding(s) in Company
20th Mar 201712:22 pmRNSHolding(s) in Company
17th Mar 20177:00 amRNSNotice of AGM
14th Mar 20172:30 pmRNSHolding(s) in Company
13th Mar 201712:12 pmRNSDirector/PDMR Shareholding
1st Mar 20177:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.